Norwegian smallcap biotech Nordic Nanovector recently had a major capitulation event after touch the bottom of yearlong downtrend fueled by weak biotech sentiment on Oslo stock exchange as well as a pronounced distrust to CEO in the norwegian investor community.
After former CEO Lugi Costa resigned sentiment has changed drastically, and the stock looks poised to make a leap back to the old NOK 68-94 trading range. Close above NOK 64 the nearest days would be a strong buy signal.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.